Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP839351.RAWssKsGiAqT4sQHzfbrVRafVbJ4_ahtdftDr7LVlKQ0A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP839351.RAWssKsGiAqT4sQHzfbrVRafVbJ4_ahtdftDr7LVlKQ0A130_assertion type Assertion NP839351.RAWssKsGiAqT4sQHzfbrVRafVbJ4_ahtdftDr7LVlKQ0A130_head.
- NP839351.RAWssKsGiAqT4sQHzfbrVRafVbJ4_ahtdftDr7LVlKQ0A130_assertion description "[The subjects of this study were 45 patients with locally advanced breast cancer (LABC), who received the cyclophosphamide, adriamycin, and 5-fluorouracil (CAF) regimen as NACT.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP839351.RAWssKsGiAqT4sQHzfbrVRafVbJ4_ahtdftDr7LVlKQ0A130_provenance.
- NP839351.RAWssKsGiAqT4sQHzfbrVRafVbJ4_ahtdftDr7LVlKQ0A130_assertion evidence source_evidence_literature NP839351.RAWssKsGiAqT4sQHzfbrVRafVbJ4_ahtdftDr7LVlKQ0A130_provenance.
- NP839351.RAWssKsGiAqT4sQHzfbrVRafVbJ4_ahtdftDr7LVlKQ0A130_assertion SIO_000772 21431478 NP839351.RAWssKsGiAqT4sQHzfbrVRafVbJ4_ahtdftDr7LVlKQ0A130_provenance.
- NP839351.RAWssKsGiAqT4sQHzfbrVRafVbJ4_ahtdftDr7LVlKQ0A130_assertion wasDerivedFrom befree-20140225 NP839351.RAWssKsGiAqT4sQHzfbrVRafVbJ4_ahtdftDr7LVlKQ0A130_provenance.
- NP839351.RAWssKsGiAqT4sQHzfbrVRafVbJ4_ahtdftDr7LVlKQ0A130_assertion wasGeneratedBy ECO_0000203 NP839351.RAWssKsGiAqT4sQHzfbrVRafVbJ4_ahtdftDr7LVlKQ0A130_provenance.